USMD Holdings (USMD Holdings) COGS-to-Revenue : 0.00 (As of Jun. 2016)

View and export this data going back to 2012. Start your Free Trial

What is USMD Holdings COGS-to-Revenue?

USMD Holdings's Cost of Goods Sold for the three months ended in Jun. 2016 was $0.0 Mil. Its Revenue for the three months ended in Jun. 2016 was $81.8 Mil.

USMD Holdings's COGS to Revenue for the three months ended in Jun. 2016 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. USMD Holdings's Gross Margin % for the three months ended in Jun. 2016 was N/A%.

USMD Holdings COGS-to-Revenue Historical Data

The historical data trend for USMD Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

USMD Holdings COGS-to-Revenue Chart

USMD Holdings Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

COGS-to-Revenue

Get a 7-Day Free Trial

USMD Holdings Quarterly Data
	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

USMD Holdings COGS-to-Revenue Calculation

USMD Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2015 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	325.153
	=	0.00

USMD Holdings's COGS to Revenue for the quarter that ended in Jun. 2016 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	81.773
	=	0.00

USMD Holdings (NAS:USMD) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

USMD Holdings's Gross Margin % for the three months ended in Jun. 2016 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 81.773
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

USMD Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of USMD Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

USMD Holdings (USMD Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » USMD Holdings Inc (NAS:USMD) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.usmdinc.com

USMD Holdings Inc is a Delaware corporation formed on May 7, 2010. The Company is a health care management company. It provides healthcare services to patients and management and operational services to hospitals and other healthcare service providers. The Company provides healthcare services to patients in physician clinics, hospitals and other healthcare facilities, including cancer treatment centers and anatomical pathology and clinical laboratories. A wholly owned subsidiary of the Company is the sole member of a Texas Certified Non-Profit Health Organization that owns and operates a multi-specialty physician group practice (USMD Physician Services) in the Dallas-Fort Worth, Texas metropolitan area. Through other wholly owned subsidiaries, the Company provides management and operational services to two short-stay hospitals in the Dallas-Fort Worth, Texas metropolitan area and provides management and/or operational services to three cancer treatment centers in three states and 22 lithotripsy service providers (i.e., kidney stone treatment) located in the South-Central United States. Of these managed entities, the Company has limited ownership interests in the two hospitals, two cancer treatment centers and 20 lithotripsy service providers. In addition, the Company wholly owns and operates two clinical laboratories, one anatomical pathology laboratory, one cancer treatment center and two lithotripsy service providers in the Dallas-Fort Worth, Texas metropolitan area. The Company operates in one physician-led integrated health system segment. It competes for patients with other integrated health systems, physician practices, hospitals, outpatient surgery centers, diagnostic facilities and other free-standing facilities.

Executives

Breaux Castleman

director

7 TECHNOLOGY DRIVE, IRVINE CA 92618

USMD Holdings (USMD Holdings) Headlines

No Headlines